U.S. Multiple Sclerosis Therapies Markets
U.S. Multiple Sclerosis Therapies Markets
RELEASE DATE
24-Jul-2002
24-Jul-2002
REGION
North America
North America
Research Code: A182-01-00-00-00
SKU: HC00830-NA-MR_04528
$2,450.00
In stock
SKU
HC00830-NA-MR_04528
Description
This report provides revenue forecasts, market shares, projected prevalence, diagnosed and treated populations, market and technology trends, and existing and emerging therapeutics. Major market challenges, drivers and restraints, and strategic recommendations to overcome market challenges are discussed. There is a competitive and product analysis of the major market participants and Market Engineering Awards are presented in various categories.
Table of Contents
Executive Summary
- Executive Summary
Disease Overview
- Overview
- Prevalence and Incidence
- Clinical Presentation
- Patient Demographics
- Disease Sub-types
- Diagnosis
Product Analysis
- Goals of Treatment
- Avonex
- Betaseron
- Copaxone
- Rebif
Demand Analysis
- Benign Multiple Sclerosis
- Relapsing Remitting Multiple Sclerosis
- Secondary Progressive Multiple Sclerosis
- Primary Progressive Multiple Sclerosis
- Monosymptomatic Multiple Sclerosis
Market Dynamics
Competitive Overview
Research and Development
- Market Engineering Analysis
- Medium To High Impact Market Drivers
- Low To Medium Impact Market Drivers
- Market Challenges
- Market Restraints
Market Engineering Awards
- Market Participants
- Products In Development
Revenue Forecasts
Strategic Recommendations
Related Research
Popular Topics
This report provides revenue forecasts, market shares, projected prevalence, diagnosed and treated populations, market and technology trends, and existing and emerging therapeutics. Major market challenges, drivers and restraints, and strategic recommendations to overcome market challenges are discussed. There is a competitive and product analysis of the major market participants and Market Engineering Awards are presented in various categories.
No Index | Yes |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | A182-01-00-00-00 |
Is Prebook | No |